Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...